The addition of a CXCR4 blocking antibody abolished the CLL IL-10 response to CXCL12, further confirming the notion that the CXCL12–CXCR4 axis is critical for IL-10 production by B-CLL cells. Here, CXCL12 is linked to B-cell chronic lymphocytic leukemia.